the world's headlines, one feed
Employers have grappled with soaring demand for GLP-1 drugs such as Ozempic and Wegovy, which can cost thousands of dollars per patient annually.
We haven't written up this one. CNBC has the full story — the link below goes straight to it.
The remittance giant is rolling out Stablecard across 37 markets, targeting cross-border payments and consumers seeking US dollar-denominated savings in volatile economies.
Hyperscalers' pain at the level of capex is a chipmaker's potential gain
Employers have grappled with soaring demand for GLP-1 drugs such as Ozempic and Wegovy, which can cost thousands of dollars per patient annually.
Parts of a SpaceX rocket reportedly crashed into the moon on Wednesday
Vancouver, B.C., Aug. 05, 2026 (GLOBE NEWSWIRE) — The Vancouver Fraser Port Authority will host its annual Port Day on Saturday, August 29, at Canada Place, inviting the community to learn about the…